An italian company, operating in the biotechnology field in South Italy, is looking for entering in contact with research or business entities dealing with research or offering new treatments to cure or make early diagnosis and prevention of the celiac disease. Intellectual property can be acquired under a license agreement or commercial with technical assistance.
The Italian small company is a university spin-off dealing with biotech research for diagnostic applications in the agro-food, environmental and medical field.
The enteprise has identified a potential market for products addressing the problem of the celiac disease and its complications and is interested to develop new technology-based solutions that may be incorporated in products to be commercialised towards the identified market segment of people affected by celiac disease.
The interest is in identifying new treatment and easy to detect early diagnostic approaches that can be further developed and used to obtain safer products towards the target consumers.
The SME is interested in entering in contact with potential sellers, especially those working on vaccines to protect celiac disease patients from gluten exposure, to close a licence or commercial agreement.
- Type of partner sought: For celiac disease there is currently only one known, effective treatment that is a gluten-free diet.
The request regards a product or a patent, a treatment procedure or a device to early detect or treat celiac disease.
The final aim is to purchase or to buy a licence.
No collaboration is sought at this stage.
- Specific area of activity of the partner: Looking for an industrial company, academy, or research organisation to start a cooperation agreement for patents exploitation or to buy a license.
The partner may be a research performer or a manufacturer/distributor to sign a commercial or an exploitation agreement.
02/04/2019 - UK Funding for Innovation
04/06/2019 - Future of Building 2019